DICE Therapeutics Inc (DICE) Earnings History & Surprises

NASDAQ:DICEUS23345J1043

Current stock price

47.55 USD
+0.03 (+0.06%)
At close:
47.59 USD
+0.04 (+0.08%)
After Hours:

DICE Earnings overview

Past quarterly earnings results for DICE Therapeutics Inc (DICE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
N/A
Period
Q2 / 2023
EPS Estimate
-$0.66
Revenue Estimate

Last Reported

Most Recent
Release Date
Aug 10, 2023
Period
Q1 / 2023
EPS Reported
-$0.54
EPS Surprise
9.57%
Revenue Surprise
%

Beat Rate

Last 8 Quarters
0%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2023 -0.54 -0.60 9.57% -8.00% - -
Q4 2022 -0.51 -0.50 -2.95% -15.91% - -
Q3 2022 -0.55 -0.61 9.75% 76.09% - -
Q2 2022 -0.58 -0.57 -2.46% - - -100.00%
Q1 2022 -0.50 -0.55 9.22% - - -
Q4 2021 -0.44 -0.60 26.26% - 102K -100.00% -100.00%
Q3 2021 -2.30 -0.51 -350.98% - 204K -100.00% -100.00%
Q2 2021 - - 1.125M - 150.00%
Q1 2021 - - - -
Q4 2020 - - 190K - -
Q3 2020 - - 225K - -
Q2 2020 - - 450K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

DICE EPS Q2Q GrowthDICE EPS Q2Q GrowthEPS Q2Q Growth Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 0 20 -20 40 60

Revenue Historical Q2Q growth and Acceleration

DICE Revenue Q2Q GrowthDICE Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q3/21 Q4/21 Q2/22 0 50 -50 100

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
3.48%
Max EPS beat (4)
9.75%
Min EPS beat (4)
-2.95%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, DICE has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, DICE has beaten the EPS estimates by 3.5% on average.

DICE Therapeutics Inc / DICE Earnings FAQ

Can you provide the last earnings date for DICE Therapeutics Inc?

DICE Therapeutics Inc (DICE) last reported earnings on 8/10/2023.

Did DICE stock beat earnings estimates in the most recent quarter?

DICE Therapeutics Inc (DICE) beat EPS estimates and missed revenue estimates in the most recent quarter.

How often does DICE Therapeutics Inc (DICE) beat earnings estimates?

In the last 4 quarters, DICE Therapeutics Inc (DICE) has beaten EPS estimates in 2 out of 4 releases.